ARTICLE | Company News

BTG International plc, Cancer Research Technology Ltd., The Institute of Cancer Research deal

May 24, 2004 7:00 AM UTC

Cancer Research Technology and the institute granted BGC exclusive worldwide rights to a series of patented quinazoline antitumor compounds. BGC is responsible for development, partly through a sponso...